Just Announced: (QNTM) Makes an Approx. 42% Move on Breaking News

Any content you receive is for information purposes only. Always conduct your own research. *Disseminated on Behalf of Quantum BioPharma Ltd. Krypton Street Is Putting All Eyes On (QNTM) This Morning —Wednesday, April 1, 2026 Don't Miss The Next Breakout—Get Real-Time Alerts Sent Directly To Your Phone. Up To 10X Faster Than Email. Full Coverage On (QNTM) is Starting Right Now Take A Look At (QNTM) While It's Still Early… April 1, 2026 Just Announced | (QNTM) Makes an Approx. 42% Move on Breaking News Dear Reader, Here at Krypton Street, we're always watching for developments that can shift attention quickly—and a major update just crossed the wire that's putting (QNTM) right in the spotlight. Quantum BioPharma Ltd. (NASDAQ: QNTM) has our full attention right now following confirmation that the company has formally submitted an Investigational New Dr-ug (IND) application to the U.S. FDA for its lead Multiple Sclerosis candidate, Lucid-MS. This submission marks a key step forward, supporting the company's planned Phase 2 clinical trial and advancing its broader clinical development timeline. With Phase 1 already completed and showing a favorable safety profile, the next phase is now positioned to move ahead pending FDA clearance. At the same time, (QNTM) is already showing strong momentum in the market—tapping $5.44 earlier today, representing an approximate 42% move from yesterday's $3.81 range—while also triggering multiple bullish signals on TradingView's technical analysis platform. When clinical milestones and technical momentum begin aligning like this, it tends to draw increased attention quickly. If you missed my earlier email coverage, keep reading to quickly get up to speed on why we're so excited to be highlighting (QNTM) today. ===== Here at Krypton Street, we're always tracking where breakthrough science meets emerging market momentum—and right now, the biopharmaceutical landscape is showing a clear shift toward data-driven therapeutic development, as advanced computing becomes increasingly important in the search for new treatments. Companies operating at the intersection of medical research and computational analysis are drawing added attention for their ability to streamline discovery and validation efforts. This model is becoming especially relevant in areas such as neurodegenerative and metabolic disorders, where unmet medical needs remain significant. The combination of specialized science and technology-driven analysis is helping shape a new generation of biotech companies with broader strategic flexibility. Quantum BioPharma Ltd. (NASDAQ: QNTM) is one example of this evolving approach, integrating advanced computing with specialized medical research to support the development of novel candidates. Which is exactly why (QNTM) just hit our radar and is topping our watchlist this morning—Wednesday, April 1, 2026. But keep in mind, (QNTM) has less than 4M shares listed as available to the public. When companies have small floats like this, the potential exists for big moves if demand begins to shift. Analyst Targets Suggest 700% to Over 1,000% Upside Potential In addition, several analysts have published targets on (QNTM) that imply substantial upside potential from its recent $4 range. Singular Research set a $35.50 target on (QNTM), which suggests over 700% upside potential. Kingswood Capital Partners set a $45 target on (QNTM), which suggests over 1,000% upside potential from its recent range. Formerly known as Lucid BioPharma, the company rebranded to reflect this focus. With a pipeline spanning neurodegenerative diseases and metabolic disorders, the company is building a hybrid model that connects traditional dr-ug discovery with the next phase of biotech innovation. And when you begin to look more closely at the company's clinical assets, strategic positioning, and technology-driven model, it becomes easier to see why (QNTM) has started drawing added attention. Here's a closer look at what is driving our interest. Integrating Technology and Therapeutics Quantum BioPharma Ltd. (NASDAQ: QNTM) is a clinical-stage biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative, inflammatory, and metabolic disorders. The company's mission is to develop novel solutions for brain and inflammatory disorders through a proprietary platform that combines traditional pharmacology with advanced computational analysis. By focusing on indications with significant patient populations and limited existing treatment options, (QNTM) aims to improve quality of life across a broad patient base. The company's core strategy involves the dual advancement of its clinical assets and its technology-driven discovery engine. This approach allows (QNTM) to move its own proprietary candidates through the regulatory path while identifying potential out-licensing pathways early in the development cycle. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., the company is focused on the research and development of its lead compound, Lucid-MS. Clinical Pipeline and Core Research Areas The (QNTM) research portfolio is currently prioritized toward therapeutic areas where current standards of care are insufficient, specifically neurodegenerative and neuropsychiatric diseases. Its lead candidate, Lucid-MS (Lucid-21-302), is a patented new chemical entity designed to prevent and reverse myelin degradation, the underlying mechanism of Multiple Sclerosis (MS). Unlike current dr-ugs that require injection or infusion, Lucid-MS is being developed as an oral formulation. Beyond MS, the company has completed dosing in oral toxicity studies supporting a future Investigational New Dr-ug (IND) application for other neurodegenerative conditions. (QNTM) also invented unbuzzd™, a dietary supplement designed to accelerate alcohol metabolism. A recent double-blind, peer-reviewed clinical trial published in the World Journal of Pharmaceutical and Medical Research demonstrated that unbuzzd™ reduced Blood Alcohol Concentration (BAC) more than 40% faster than a placebo within the first 30 minutes. Strategic Partnerships and Intellectual Property A major component of Quantum BioPharma's growth is its commitment to building a robust intellectual property (IP) moat. The company has rights to patent families licensed on an exclusive basis, protecting its neuroprotective compounds and computational discovery algorithms. On March 30, 2026, the company signed a binding Letter of Intent (LOI) with Allucent, a global contract research organization, to conduct a Phase 2 clinical trial for Lucid-MS. (QNTM) also retains significant financial optionality through its spun-out assets. The company holds a 19.84% ownership stake in Unbuzzd Wellness Inc. and is entitled to royalty payments of 7% of sales until they reach $250M, at which point the royalty remains at 3% in perpetuity. Furthermore, the company retains a tax loss carry forward of approximately C$130M, which can be used to offset future tax obligations against profits. Recent Developments [Phase 2 Trial Milestone]: On March 30, 2026, Quantum announced it expects to initiate the Phase 2 trial for Lucid-MS in the second quarter of 2026, following its strategic partnership with Allucent. [Peer-Reviewed Validation]: On March 23, 2026, a groundbreaking clinical trial for unbuzzd™ was published in a peer-reviewed journal, showing definitive acceleration of BAC reduction and symptom improvement. [Audited Financial Results]: On March 27, 2026, the company released its 2025 year-end audited results, confirming a strong balance sheet with no "going concern" status. [Principal Investigator Appointment]: On March 26, 2026, the company appointed a Principal Investigator for its upcoming MS Phase 2 study, further solidifying its clinical execution plan. [Toxicity Study Completion]: The company completed 180-day repeated dose oral toxicity studies for Lucid-MS, reporting no toxicity or significant side effects, supporting its move into human efficacy trials. Financial Positioning and Market Potential As of March 27, 2026, (QNTM) reported cash and digital assets totaling $11.3M. Management believes this provides sufficient working capital to sustain basic operations beyond January 2028, representing a runway of nearly two years. The company also reduced its trade payables by approximately 50% over the last year, from $4.1M to $2.0M. Operating in the $38B Multiple Sclerosis market (projected by 2030) and the $238B mental health market, Quantum is positioned to capture value through its first-in-class neuroprotective therapies. With a market capitalization of approximately $22M, the company presents a potential value-inflection point as it transitions into Phase 2 clinical data readouts. 7 Factors Putting (QNTM) On The Top Of This Morning's Watchlist —Wednesday, April 1, 2026… 1. Analyst Coverage: Several analyst targets on (QNTM), including $35.50 from Singular Research and $45 from Kingswood Capital Partners, suggest over 700% to more than 1,000% upside potential from its recent $4 range. 2. Low Float: With fewer than 4M shares listed as available to the public, (QNTM)'s small float could witness the potential for big moves if demand begins to shift. 3. Phase 2: A binding LOI with Allucent and an expected Phase 2 start in Q2 2026 give (QNTM) a near-term clinical milestone to watch. 4. Oral MS: Lucid-MS gives (QNTM) a lead candidate aimed at Multiple Sclerosis with an oral formulation rather than injection or infusion. 5. Peer Review: Published peer-reviewed data showing unbuzzd™ reduced BAC more than 40% faster than placebo within the first 30 minutes adds scientific validation to part of the (QNTM) portfolio. 6. Asset Value: A 19.84% stake in Unbuzzd Wellness, royalty rights tied to sales, and an approximately C$130M tax loss carryforward give (QNTM) several additional balance-sheet and asset-based talking points. 7. Capital Runway: As of March 27, 2026, (QNTM) reported $11.3M in ca-sh and digital assets, with management stating this supports basic operations beyond January 2028. Take A Look At (QNTM) While It's Still Early… What continues to stand out about (QNTM) is how multiple factors are beginning to align at the same time. A small float of fewer than 4M shares creates the potential for big moves if demand begins to shift, while published analyst targets suggest 700% to more than 1,000% upside potential from recent levels is putting (QNTM) at the top of our watchlist right now. At the same time, the expected Phase 2 initiation in Q2 2026 marks an important clinical step forward, supported by a lead MS candidate designed as an oral formulation rather than injection or infusion. Beyond the pipeline, peer-reviewed data validating unbuzzd™ and a reported $11.3M in ca-sh and digital assets, with runway projected beyond January 2028, add additional layers to the overall picture. When combined with royalty rights, a 19.84% stake in Unbuzzd Wellness, and a C$130M tax loss carryforward, (QNTM) presents a mix of clinical progress and underlying asset value that could start to draw increased attention. (QNTM) is our primary focus this morning. Take a look at (QNTM) while it's still early. Watch for my next update, it could be hitting any moment. Sincerely, Alex Ramsay Co-Founder / Managing Editor Krypton Street Newsletter KryptonStreet.com ("KryptonStreet" or "KS" ) is owned by Media 1717 LLC, a single member limited liability company. Data is provided from third-party sources and KS is not responsible for its accuracy. Make sure to always do your own research and due diligence on any day and swing profile KS brings to your attention. Any emojis used do not have a specific defined meaning, and may be used inconsistently. We do not provide personalized in-vest-ment advice, are not in-vest-ment advisors, and any profiles we mention are not suitable for all in-vest-ors. Quantum BioPharma Ltd. (QNTM:US) (QNTM:CA) previously changed their company name and symbols from FSD Pharma Inc. (HUGE:US) (QNTM:CA) Pursuant to an agreement between Media 1717 LLC and TD Media LLC, Media 1717 LLC has been hired for a period beginning on 03/31/2026 and ending on 04/01/2026 to publicly disseminate information about (QNTM:US) (QNTM:CA) via digital communications. Under this agreement, TD Media LLC has paid Media 1717 LLC seven thousand five hundred USD ("Funds"). To date, including under the previously described agreement, Media 1717 LLC has been paid fifty eight thousand USD ("Funds"). These Funds were part of the thirty five thousand USD funds that TD Media LLC received from a third party named Awareness Consulting Network LLC who did receive the Funds directly or indirectly from the Issuer and does not own stock in the Issuer but the reader should assume that the clients of the third party own shares in the Issuer, which they will liquidate at or near the time you receive this communication and has the potential to hurt share prices. Neither Media 1717 LLC, TD Media LLC and their member own shares of (QNTM:US) (QNTM:CA). Please see important disclosure information here: https://kryptonstreet.com/disclosure/qntm-kIb3k/#details

Media 1717 LLC | 6586 W Atlantic Ave, Unit #2086, Delray Beach, FL 33446 Unsubscribe Update Profile | About our service provider Sent by alex@kryptonstreet.com

The Great AI Delusion

Your Retirement Is Dying  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

April 01, 2026   |   Listen online   |   Read online   Teeka Tiwari What I'm about to say will offend you. It might even make you delete this email. But if you value your retirement, you'll sit down and read every word. The American investor is asleep. You've been fed a lie by Wall Street for decades: "Buy and hold. Diversify. Trust the system." That system is currently driving your retirement account into a concrete wall at 100 miles per hour. And the people cheering from the sidelines are the ones looting your pockets. The Pelosi Paradox Let's look at the facts. I don't care about Nancy Pelosi's politics, and neither should you. But if you want to get wealthy, you cannot ignore her profit ledger. In 2023, while the average American struggled with inflation, Pelosi's portfolio returned 65.5%. Pelosi – a lifelong politician who never spent a day working on a trading desk or in an asset manager's office – somehow managed a 65.5% return on her investment portfolio? That's more than double the return of the S&P 500 that year. A year later, she walked away with a $4.3 million windfall on her Nvidia position. That was a 178% gain in less than 12 months. That's nearly 20x times greater than her annual Congressional salary of $223,500. And get this… She didn't even buy a single share. She didn't just beat the market. She embarrassed it. She outperformed Warren Buffett, Stanley Druckenmiller, and Citadel's Ken Griffin. These men are giants in the money management world. And yet she outperformed the greatest hedge fund minds of our generation. How does a career politician – someone who, again, has never spent a day on a trading desk – clock a 178% gain on Nvidia? She simply knows the real rules of the game. She knows that in Washington and on Wall Street, there is a "private" playbook for the elite, and a "public" one for the suckers.     Every AI Company Travels the Same Road. These 3 Stocks Own It. Microsoft, Oracle, Palantir trillions in market cap vaporized. The AI shakeout is here, and it's brutal. But beneath the surface, a colossal $7.9 TRILLION tsunami of cash is flooding into AI infrastructure. This isn't about picking the next Nvidia… it's about owning the roads every AI company must travel. Big T has pinpointed three overlooked companies that are not just surviving, but dominating this shift. They are the essential, behind-the-scenes players that every AI innovation relies on, making them immune to the market's volatility and poised for explosive growth. Big T is holding an urgent briefing, next Thursday, April 9th at 8 pm ET, to reveal these three immune stocks and a free pick that could double your money.  See Big T's 3 Plays     The $3 Trillion Slaughter Wall Street is a fee-machine. Firms like Goldman Sachs and Morgan Stanley don't care if you make money… They care that you stay in the game so they can skim their fat profit margins off your back. They've convinced you that Big Tech is a safe haven. It isn't. It's a bubble I've been warning you about since last year. I'm not saying that artificial intelligence (AI) has no value. Of course, it has value. It's as important as electricity and the internet COMBINED. What I'm saying is this: The companies you're betting on to capture that value are the wrong companies. The Magnificent Seven has already seen $3.3 trillion in market value vaporized. Friends, this isn't a correction. It's the beginning of the end for the current AI leaders. From Meta to Microsoft, the carnage is everywhere. Oracle is down 60%. Palantir is down 40%. The AI trade is unraveling. And if you're following the standard retail playbook, your life savings will unravel with it. I want to be crystal clear: We are staring at a collapse that will make the 2000 dot-com bust look like a rounding error. Let me say this again. We're staring at a collapse bigger than the dot-com bubble. I call it The Final AI Shakeout. No one knows how the AI race will play out. Who will be the ultimate winners of AI? Who will be the ultimate losers? I'm not smart enough to know the answer. You're not smart enough to know the answer. Even Pelosi and Druckenmiller aren't smart enough to know the answer. Everyone is guessing right now. That's why so many Big Tech names are getting scorched. Understand this: These stocks started melting down long before the Iran war. So even if we get a ceasefire tomorrow, it doesn't change anything for these companies. Friends, if you're feeling hopeless, confused, and scared, I don't blame you. You have every right to be. That's because the winners of the AI race won't be the names you see on CNBC every morning. Those stocks are being annihilated as we speak. The real money – the Pelosi money – is moving in the shadows. As Big Tech incinerates its balance sheets trying to win the AI battle… three companies will rally as much as 5x, 10x, even 20x from here. It's all because no matter who wins the AI race, everyone must buy from them. These companies control three separate "toll roads" that all AI competitors must travel down. They're the exit ramp from portfolio ruin to a fully funded retirement. That's why you must get them in your portfolio if you want to survive The Final AI Shakeout. It's time to stop being a victim of the system and start being a beneficiary of it. If you want to know how the game is actually played – and how to win it – I'll see you on Thursday, April 9 at 8 p.m. ET. That's when I'll show you three stocks poised for massive gains no matter who wins the AI race. And it's all because the AI race must run through these three companies. Here's the thing: I don't want you to buy a single share of them. Because on April 9 at 8 p.m. ET, I'm going to hand you the same playbook Washington insiders like Pelosi and the Wall Street elite are using to position themselves for The Final AI Shakeout. And no, I'm not talking about regular options trading, futures, or anything extra risky. You may be thinking, "Teeka, I'm not a hedge fund manager or a political insider. Can I really make 5x, 10x, or even 20x in less than a month using this playbook?" That's a great question. So we reached out to some of our subscribers. The results shocked us. In my next essay, I'll reveal what everyday people are doing once they learn how to use this playbook. Let the Game Come to You! Big T P.S. As a special thank you for attending, I'll also give away the name of an AI stock I believe could double in the coming year. It's a company on the receiving end of $7.9 trillion in AI infrastructure spending. Be sure to secure your spot. Then, mark your calendar and set a reminder for April 9 at 8 p.m. ET. That's when I'll reveal all of my research to you. Remember it's free to attend. Share The Digital Asset Daily You currently have 0 referrals. Click to Share Or copy and paste this link to others: https://tiwariresearchgroup.com/subscribe?ref=smdz7lJ2jD   Update your email preferences or unsubscribe here © 2026 Tiwari Research Group 1607 Ponce De Leon Ave San Juan, Puerto Rico 00909, Puerto Rico Terms of Service

Bitcoin's Critical $63K Level: Hold Here or Flush to $30-50K

The Make-or-Break Zone That Determines Whether We Correct Now or Suffer Later

🚨 I’ll be live at 11:30 a.m. ET with Jack Carter🚨  We’ll share the report with today’s top Triple Income Strategy trades, break down the setups, discuss what’s moving markets and more [tap to join us for Market Masters] Bitcoin's Critical $63K Level: Hold Here or Flush to $30-50K Instead of Later Bitcoin is approaching a level that could determine whether the market holds steady or unravels far faster than most traders expect. So today we'll discuss why the $63K zone matters and what it signals about the next major swing. If this area survives, Bitcoin may grind upward into late spring, but if it fails, the market could flush straight into a deep correction that resets the entire structure. I'm covering the key signals guiding this setup and why Ethereum's behavior might already be hinting at the path ahead. If you want to stay ahead of the next big move, make sure you read the full breakdown and see what that $63K line is really telling us. Get the full story, then join us live at 11:30 a.m. ET weekdays for Market Masters!   Timing Makes All the Difference I’m also live at 9:15 a.m. ET weekdays for Morning Monster and at 5 p.m. Tuesdays for 30 Minutes of Awesome — bring your ticker and I’ll analyze it in real time! Visit me @JeffryTurnmireTrading on YouTube. _____________________________________________________   Have You Seen the 99.7% Historical Edge Backing My $50K Income Challenge?  You won't believe how straightforward it is to grow a small account consistently using just one trade a day. Leveraging this one-sided statistical pattern helped me double my trading account over the last year…     And now I'm revealing all the details behind it and more…   Take a Look in Here Now _____________________________________________________   Today’s Daily Chart Setup: Mesa Laboratories (MLAB)     This idea came directly from my Daily Chart Setup that automatically signals potential plays.  See the strategy behind these signals!   • MLAB is a new potential entry. Target: 102.05 Stop below: 70.06 • MLAB has a historical win rate of 90.91% • MLAB has a profit factor of 9.23 • MLAB trades last 102 trading days on average over 22 trades since 1984. This is for informational and educational purposes only. There is inherent risk in trading, so trade at your own risk. Always remember that past performance is not indicative of future results. How the Daily Chart Setup Works Here’s a more detailed description of how the pattern triggers:   1. The price breaks upward through the orange Market Roadmap line.    2. Then the price goes up and down while staying above the line. Eventually, it comes down to touch the line again — this could take days, weeks or even months.    3. Once it touches the line and starts moving back up, that signals an entry.  I use Fibonacci levels for for profit targets and stop losses, and these two tools combined have helped me achieve a 77% win rate over the past six-plus years! Jeffry Turnmire Jeffry Turnmire Trading I host my Morning Monster livestream at 9:15 a.m. ET weekdays on YouTube, and then 30 Minutes of Awesome at 5 p.m. ET each Tuesday! Visit me @JeffryTurnmireTrading on YouTube. You can also follow along and join the conversation for real-time analysis, trade ideas, market insights and more in my official Telegram channel! Important Note: No one from the ProsperityPub team or Jeffry Turnmire Trading will ever message you directly on Telegram.  I’m just a regular dude in Knoxville, Tennessee: a husband, father, civil engineer, urban farmer, maker and trader. I've been at this trading thing with real money for 20-plus years, and started paper trading over 35 years ago. I have a knack for making some epic predictions that just may very well come true. Why share them? Because I like helping other people — it's the Eagle Scout in me. *This is for informational and educational purposes only. There is inherent risk in trading, so trade at your own risk.

🚨 I’ll be live at 11:30 a.m. ET with Jack Carter🚨    We’ll share the report with today’s top Triple Income Strategy trades, break down the setups, discuss what’s moving markets and more [tap to join us for Market Masters] Bitcoin's Critical $63K Level: Hold Here or Flush to $30-50K Instead of Later   Bitcoin is approaching a level that could determine whether the market holds steady or unravels far faster than most traders expect.   So today we'll discuss why the $63K zone matters and what it signals about the next major swing.   If this area survives, Bitcoin may grind upward into late spring, but if it fails, the market could flush straight into a deep correction that resets the entire structure.   I'm covering the key signals guiding this setup and why Ethereum's behavior might already be hinting at the path ahead.   If you want to stay ahead of the next big move, make sure you read the full breakdown and see what that $63K line is really telling us.   Get the full story, then join us live at 11:30 a.m. ET weekdays for Market Masters!   Timing Makes All the Difference I’m also live at 9:15 a.m. ET weekdays for Morning Monster and at 5 p.m. Tuesdays for 30 Minutes of Awesome — bring your ticker and I’ll analyze it in real time!   Visit me @JeffryTurnmireTrading on YouTube. _____________________________________________________   Have You Seen the 99.7% Historical Edge Backing My $50K Income Challenge?   You won't believe how straightforward it is to grow a small account consistently using just one trade a day.   Leveraging this one-sided statistical pattern helped me double my trading account over the last year…   And now I'm revealing all the details behind it and more…   Take a Look in Here Now _____________________________________________________   Today’s Daily Chart Setup: Mesa Laboratories (MLAB)     This idea came directly from my Daily Chart Setup that automatically signals potential plays.    See the strategy behind these signals!   MLAB is a new potential entry. Target: 102.05 Stop below: 70.06 MLAB has a historical win rate of 90.91% MLAB has a profit factor of 9.23 MLAB trades last 102 trading days on average over 22 trades since 1984. This is for informational and educational purposes only. There is inherent risk in trading, so trade at your own risk. Always remember that past performance is not indicative of future results.   How the Daily Chart Setup Works   Here’s a more detailed description of how the pattern triggers:     1. The price breaks upward through the orange Market Roadmap line.    2. Then the price goes up and down while staying above the line. Eventually, it comes down to touch the line again — this could take days, weeks or even months.    3. Once it touches the line and starts moving back up, that signals an entry.  I use Fibonacci levels for for profit targets and stop losses, and these two tools combined have helped me achieve a 77% win rate over the past six-plus years! Jeffry Turnmire Jeffry Turnmire Trading   I host my Morning Monster livestream at 9:15 a.m. ET weekdays on YouTube, and then 30 Minutes of Awesome at 5 p.m. ET each Tuesday!   Visit me @JeffryTurnmireTrading on YouTube.   You can also follow along and join the conversation for real-time analysis, trade ideas, market insights and more in my official Telegram channel!   Important Note: No one from the ProsperityPub team or Jeffry Turnmire Trading will ever message you directly on Telegram.    I’m just a regular dude in Knoxville, Tennessee: a husband, father, civil engineer, urban farmer, maker and trader.   I've been at this trading thing with real money for 20-plus years, and started paper trading over 35 years ago. I have a knack for making some epic predictions that just may very well come true. Why share them? Because I like helping other people — it's the Eagle Scout in me.     *This is for informational and educational purposes only. There is inherent risk in trading, so trade at your own risk.

ABOUT US:  We believe that the opportunity for financial literacy and freedom belongs to all people, not just those who already have years of investing experience. Jeffry Turnmire Trading provides an array of educational services and products that will help you navigate the markets and become a better investor. Trading is made simple through our online forum full of trading techniques to give you the best tools to kick-start your investing journey. We offer collaborative webinars and training; we love to teach. No matter the opportunity, we bring together a strong community of like-minded traders to focus on analyzing market news as it’s presented each day. DISCLAIMER: FOR INFORMATION PURPOSES ONLY. The materials presented from Jeffry Turnmire Trading are for your informational purposes only. Neither Jeffry Turnmire Trading nor its employees offer investment, legal or tax advice of any kind, and the analysis displayed with various tools does not constitute investment, legal or tax advice and should not be interpreted as such. Using the data and analysis contained in the materials for reasons other than the informational purposes intended is at the user’s own risk. DISCLAIMER: TRADE AT YOUR OWN RISK; TRADING INVOLVES RISK OF LOSS; SEEK PROFESSIONAL ADVICE. Jeffry Turnmire Trading is not responsible for any losses that may occur from transactions effected based upon information or analysis contained in the presented. To the extent that you make use of the concepts with the presentation material, you are solely responsible for the applicable trading or investment decision. Trading activity, including options transactions, can involve the risk of loss, so use caution when entering any option transaction. You trade at your own risk, and it is recommended you consult with a financial advisor for investment, legal or tax advice relating to options transactions.  Please visit https://prosperitypub.com/terms-conditions/ for our full Terms and Conditions. Unsubscribe This email was sent to ahmedwithnour@gmail.com by Prosperity Pub 101 Marketside Ave, Suite 404 PMB 318, Ponte Vedra, Florida 32081, United States Prosperity Pub

ABOUT US:  We believe that the opportunity for financial literacy and freedom belongs to all people, not just those who already have years of investing experience. Jeffry Turnmire Trading provides an array of educational services and products that will help you navigate the markets and become a better investor. Trading is made simple through our online forum full of trading techniques to give you the best tools to kick-start your investing journey. We offer collaborative webinars and training; we love to teach. No matter the opportunity, we bring together a strong community of like-minded traders to focus on analyzing market news as it’s presented each day. DISCLAIMER: FOR INFORMATION PURPOSES ONLY. The materials presented from Jeffry Turnmire Trading are for your informational purposes only. Neither Jeffry Turnmire Trading nor its employees offer investment, legal or tax advice of any kind, and the analysis displayed with various tools does not constitute investment, legal or tax advice and should not be interpreted as such. Using the data and analysis contained in the materials for reasons other than the informational purposes intended is at the user’s own risk. DISCLAIMER: TRADE AT YOUR OWN RISK; TRADING INVOLVES RISK OF LOSS; SEEK PROFESSIONAL ADVICE. Jeffry Turnmire Trading is not responsible for any losses that may occur from transactions effected based upon information or analysis contained in the presented. To the extent that you make use of the concepts with the presentation material, you are solely responsible for the applicable trading or investment decision. Trading activity, including options transactions, can involve the risk of loss, so use caution when entering any option transaction. You trade at your own risk, and it is recommended you consult with a financial advisor for investment, legal or tax advice relating to options transactions.  Please visit https://prosperitypub.com/terms-conditions/ for our full Terms and Conditions. Unsubscribe This email was sent to ahmedwithnour@gmail.com by Prosperity Pub 101 Marketside Ave, Suite 404 PMB 318, Ponte Vedra, Florida 32081, United States Prosperity Pub